SYSTEMIC ISOTRETINOIN AND ORAL HEALTH: SALIVARY, MUCOSAL, AND PERIODONTAL CHANGES AND IMPLICATIONS FOR DENTAL PRACTICE
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6637Keywords:
Isotretinoin, Oral Health, Xerostomia, Salivary Flow, Oral Mucosa, Periodontal Health, Dental CariesAbstract
Systemic isotretinoin is widely used for the treatment of severe acne and is frequently associated with mucocutaneous adverse effects. Oral manifestations may include xerostomia, reduced salivary flow, cheilitis, mucosal discomfort, and changes in periodontal parameters, but their clinical significance for dental practice remains incompletely defined. This narrative review summarizes current evidence on salivary, mucosal, and periodontal changes associated with systemic isotretinoin therapy and discusses their implications for dental care. A structured literature search was conducted primarily in PubMed/MEDLINE and supplemented by Google Scholar, Scopus, and Web of Science. Original clinical studies, systematic reviews, and selected mechanistic studies relevant to isotretinoin-associated oral changes were considered. Reduced salivary flow and xerostomia are the most consistently reported oral effects and appear to be largely transient. Cheilitis and oral dryness are common, whereas burning sensations and mucosal ulcerations are reported less frequently. Reduced salivary secretion and, in some studies, decreased buffering capacity may create conditions potentially favorable to dental caries, although a direct causal relationship has not been established. Periodontal findings are heterogeneous. Some longitudinal studies report transient increases in gingival inflammation, bleeding on probing, plaque accumulation, or probing depth, whereas others show little clinical deterioration. Biomarker and microbiological studies suggest additional effects on inflammatory, extracellular-matrix, and antimicrobial pathways, but their clinical significance remains uncertain. Dental management should therefore focus on recognition of oral dryness and mucosal symptoms, individualized caries prevention, plaque control, and periodontal monitoring. Current evidence does not support isotretinoin as a direct cause of periodontitis or routine postponement of necessary dental procedures solely because of isotretinoin therapy.
References
AlJasser, R. N., Alaqeely, R. S., Al-Hoqail, I. A., Al-Haddab, M., AlQahtani, S. S., AlKenani, M. E., AlZahrani, A. M., & AlOraini, S. (2021). Association between isotretinoin (Roaccutanne) use and changes in periodontal clinical parameters and MMP-8 and MMP-9 salivary levels. Frontiers in Bioscience-Landmark, 26(7), 191–197. https://doi.org/10.52586/4933
AlJasser, R., AlAqeely, R., AlKenani, M., AlQahtani, S., AlZahrani, A., & Lambarte, R. (2022). The effect of systemic isotretinoin on salivary tissue inhibitors of metalloproteinases 1 and 2 and salivary flow rate in periodontal disease. Saudi Journal of Biological Sciences, 29(1), 148–153. https://doi.org/10.1016/j.sjbs.2021.08.079
AlJasser, R., AlAqeely, R., AlZahrani, A., AlKenani, M., AlQahtani, S., AlSarhan, M., AlOtaibi, D., & Lambarte, R. (2021). Antimicrobial effect of isotretinoin therapy on periodontal pathogens: A case-control study. Antibiotics, 10(11), 1286. https://doi.org/10.3390/antibiotics10111286
Alkanhal, N. A., Aldaij, M. H., Alkanhal, H. A., Al-Haddab, M., & Alfaifi, F. (2021). Dental decay and salivary flow in patients taking systemic isotretinoin: A prospective study. Journal of Dermatology and Dermatologic Surgery, 25(2), 80–83. https://doi.org/10.4103/jdds.jdds_122_20
Alqahtani, R. M., Alatwi, R. S., Mohammed, M. A. J., Alruwaili, D. N., Alruwaili, A. N., Alqhtani, R. M., & Alanazi, W. Z. (2026). Oral side effects of isotretinoin therapy in acne patients: A prospective study. Journal of Pharmacy & Bioallied Sciences, 18(Suppl 1), S165–S167. https://doi.org/10.4103/jpbs.jpbs_1600_25
Atalay, N., Balci, N., Toygar, H. U., Yardimci, G., & Gürsoy, U. K. (2023). Serum, saliva, and gingival tissue human β-defensin levels in relation to retinoic acid use. Journal of Periodontology, 94(5), 597–605. https://doi.org/10.1002/JPER.22-0466
Bettoli, V., Guerra-Tapia, A., Herane, M. I., & Piquero-Martín, J. (2019). Challenges and solutions in oral isotretinoin in acne: Reflections on 35 years of experience. Clinical, Cosmetic and Investigational Dermatology, 12, 943–951. https://doi.org/10.2147/CCID.S234231
Erdemir, U., Okan, G., Gungor, S., Tekin, B., Yildiz, S. O., & Yildiz, E. (2017). The oral adverse effects of isotretinoin treatment in acne vulgaris patients: A prospective, case-control study. Nigerian Journal of Clinical Practice, 20(7), 860–866. https://doi.org/10.4103/1119-3077.183248
Erduran, F., Çoşlu, M. D., Karaaslan, S., & Emre, S. (2026). Isotretinoin beyond the skin: A prospective study on its impact on periodontal health. Dermatology Practical & Conceptual, 16(2), 6739. https://doi.org/10.5826/dpc.1602a6739
Günay, B., Toygar, H., Balevi, A., Gürsoy, M., Gürsoy, U. K., & Balci, N. (2026). Time-dependent effect of isotretinoin use on oral health related quality of life in acne vulgaris patients: A longitudinal study. Journal of Patient-Reported Outcomes. Advance online publication. https://doi.org/10.1186/s41687-026-01171-5
Hatakeyama, S., Hayashi, S., Yoshida, Y., Otsubo, A., Yoshimoto, K., Oikawa, Y., & Satoh, M. (2004). Retinoic acid disintegrated desmosomes and hemidesmosomes in stratified oral keratinocytes. Journal of Oral Pathology & Medicine, 33(10), 622–628. https://doi.org/10.1111/j.1600-0714.2004.00245.x
Holanda, P. M. M. de, Barbosa, K. G. N., Santos, A. F. dos, Nóbrega, D. F., Marcelos, P. G. C. L. de, Barbosa, K. L., Menezes, P. L., Islam, N. M., & Panjwani, C. M. B. R. G. (2026). Reduction of salivary flow from anti acne therapy with oral isotretinoin: A systematic review with meta-analysis. Pediatric Review: International Journal of Pediatric Research, 13(1), 12–19. https://doi.org/10.17511/ijpr.2026.i01.02
Kapała, J., Lewandowska, J., Placek, W., & Owczarczyk-Saczonek, A. (2022). Adverse events in isotretinoin therapy: A single-arm meta-analysis. International Journal of Environmental Research and Public Health, 19(11), 6463. https://doi.org/10.3390/ijerph19116463
Kautsky, M. B., Fleckman, P., & Dale, B. A. (1995). Retinoic acid regulates oral epithelial differentiation by two mechanisms. Journal of Investigative Dermatology, 104(4), 546–553. https://doi.org/10.1111/1523-1747.ep12606058
Kothari, R., Pol, D., Asnani, D., Deoghare, S., Kumar, A., & Buccha, Y. (2024). Comparative study between tacrolimus 0.1% ointment versus topical white soft petrolatum jelly in the treatment of oral retinoid-induced cheilitis. Indian Journal of Dermatology, 69(2), 202. https://doi.org/10.4103/ijd.ijd_67_23
Lynge Pedersen, A. M., & Belstrøm, D. (2019). The role of natural salivary defences in maintaining a healthy oral microbiota. Journal of Dentistry, 80(Suppl 1), S3–S12. https://doi.org/10.1016/j.jdent.2018.08.010
Nelson, A. M., Zhao, W., Gilliland, K. L., Zaenglein, A. L., Liu, W., & Thiboutot, D. M. (2008). Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells. Journal of Clinical Investigation, 118(4), 1468–1478. https://doi.org/10.1172/JCI33869
Oikarinen, K., Salo, T., Kylmäniemi, M., Palatsi, R., Karhunen, T., & Oikarinen, A. (1995). Systemic oral isotretinoin therapy and flow rate, pH, and matrix metalloproteinase-9 activity of stimulated saliva. Acta Odontologica Scandinavica, 53(6), 369–371. https://doi.org/10.3109/00016359509006003
Ornelas, J., Rosamilia, L., Larsen, L., Foolad, N., Wang, Q., Li, C. S., & Sivamani, R. K. (2016). Objective assessment of isotretinoin-associated cheilitis: Isotretinoin Cheilitis Grading Scale. Journal of Dermatological Treatment, 27(2), 153–155. https://doi.org/10.3109/09546634.2015.1086477
Örsal, E., Seven, B., Erdem, M. T., Varoğlu, E., Farimaz, H., & Ayan, A. K. (2015). Evaluation of the effect of isotretinoin on salivary gland function by Tc-99m pertechnetate imaging in acne vulgaris patients. Turkish Journal of Medical Sciences, 45(3), 674–677. https://doi.org/10.3906/sag-1402-131
Reynolds, R. V., Yeung, H., Cheng, C. E., Cook-Bolden, F., Desai, S. R., Druby, K. M., Freeman, E. E., Keri, J. E., Stein Gold, L. F., Tan, J. K. L., Tollefson, M. M., Weiss, J. S., Wu, P. A., Zaenglein, A. L., Han, J. M., & Barbieri, J. S. (2024). Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology, 90(5), 1006.e1–1006.e30. https://doi.org/10.1016/j.jaad.2023.12.017
Spring, L. K., Krakowski, A. C., Alam, M., Bhatia, A., Brauer, J., Cohen, J., Del Rosso, J. Q., Diaz, L., Dover, J., Eichenfield, L. F., Gurtner, G. C., Hanke, C. W., Jahnke, M. N., Kelly, K. M., Khetarpal, S., Kinney, M. A., Levy, M. L., Leyden, J., Longaker, M. T., … Zaenglein, A. L. (2017). Isotretinoin and timing of procedural interventions: A systematic review with consensus recommendations. JAMA Dermatology, 153(8), 802–809. https://doi.org/10.1001/jamadermatol.2017.2077
Truax, L., Hendrixson, M., Naqvi, J., & Trevino, J. (2025). Use of oral retinoids in the perioperative period by surgical specialty: A literature review. Archives of Dermatological Research, 317(1), 174. https://doi.org/10.1007/s00403-024-03750-2
Ustaoğlu, G., Güler, Ş., & Polat, M. (2020). Effect of isotretinoin on periodontal tissues and oxidative stress markers in the saliva. Turkderm-Turkish Archives of Dermatology and Venereology, 54(4), 132–137. https://doi.org/10.4274/turkderm.galenos.2020.99896
Villa, A., Connell, C. L., & Abati, S. (2015). Diagnosis and management of xerostomia and hyposalivation. Therapeutics and Clinical Risk Management, 11, 45–51. https://doi.org/10.2147/TCRM.S76282
Wolff, A., Joshi, R. K., Ekström, J., Aframian, D., Lynge Pedersen, A. M., Proctor, G., Narayana, N., Villa, A., Sia, Y. W., Aliko, A., McGowan, R., Kerr, A. R., Jensen, S. B., Vissink, A., & Dawes, C. (2017). A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: A systematic review sponsored by the World Workshop on Oral Medicine VI. Drugs in R&D, 17(1), 1–28. https://doi.org/10.1007/s40268-016-0153-9
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Gracjan Koźma, Wojciech Sielatycki , Weronika Komar, Marta Sielatycka, Marta Borkowska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
